Onderzoeker
David Nittner
- Disciplines:Morfologische wetenschappen, Oncologie
Affiliaties
- Laboratorium voor Moleculaire Kankerbiologie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf19 okt 2009 → 31 mrt 2017
Projecten
1 - 1 of 1
- Determinatie van de tumorgroeiwijze van melanomen door middel van het traceren van stamcellen.Vanaf1 okt 2013 → 30 sep 2016Financiering: FWO mandaten
Publicaties
11 - 20 van 29
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis(2022)
Auteurs: Margherita Demicco, Ginevra Doglioni, Anke Vandekeere, Alex Cuadros, David Nittner, Francesca Rizzollo, Panagiotis Karras, dorien Broekaert, Sofie Demeyer, Guy Eelen, et al.
Pagina's: 747 - + - PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia(2021)
Auteurs: Inge Govaerts, Charlien Vandersmissen, David Nittner, Johan Maertens, Nancy Boeckx, Kim De Keersmaecker, Heidi Segers, Jan Cools
- The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype(2020)
Auteurs: Jasper Wouters, David Nittner, Danny Huylebroeck, Joost van den Oord, Chris Marine
Pagina's: 2983 - 2995 - Zeb2 drives invasive and microbiota-dependent colon carcinoma(2020)
Auteurs: David Nittner, Gert De Hertogh, Sabine Tejpar
Pagina's: 620 - + - Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer(2020)
Auteurs: Jeroen Dekervel, David Nittner, Louis Libbrecht, Stéphane Plaisance, Baki Topal, An Coosemans, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt
- Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts(2020)
Auteurs: Jeroen Dekervel, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pagina's: 6907 - 6916 - CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression(2019)
Auteurs: Matteo Riva, Roxanne Wouters, Sarah Belderbos, David Nittner, Dietmar Thal, Thaïs Baert, Willy Gsell, Uwe Himmelreich, Marc Van Ranst, An Coosemans
- Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition(2019)
Auteurs: Charles De Bock, Inge Lodewijckx, Delphine Verbeke, David Nittner, Sofie Demeyer, James Dooley, Adrian Liston, Jan Cools, Bart De Strooper
- TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression(2019)
Auteurs: Flavie Luciani, David Nittner, Chris Marine
Pagina's: 482 - 494 - Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts(2019)
Auteurs: Ashenafi Shiferaw Bulle, Jeroen Dekervel, Louis Libbrecht, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pagina's: 765 - 779